Scapa Dividends - SCPA

Scapa Dividends - SCPA

Best deals to access real time data!
Monthly Subscription
for only
Level 2 Basic
Monthly Subscription
for only
UK/US Silver
Monthly Subscription
for only
VAT not included
Stock Name Stock Symbol Market Stock Type Stock ISIN Stock Description
Scapa Group Plc SCPA London Ordinary Share GB0007281198 ORD 5P
  Price Change Price Change % Stock Price Low Price High Price Open Price Close Price Last Trade
0.00 0.0% 186.00 0.00 0.00 0.00 186.00 08:25:22
more quote information »
Industry Sector

Scapa SCPA Dividends History

Announcement Date Type Currency Dividend Amount Period Start Period End Ex Date Record Date Payment Date Total Dividend Amount

Top Dividend Posts

marmar80: Looks like the loss of Convatec business didn't do as much damage as the share price is showing. Was down from 400 to below 200 on that announcement back in the days. Now we know that Scapa is demanding 83m+ from Convatec and officially Convatec's contra claim is rejected. Revenue up. Loss was made but promise of more to come from other businesses. For me it's a very solid update and can lead to an nice pay out in case of win against Convatec.
woodhawk: On the back of the recent strong results and with the potential of damages from Convatec, the share price really ought to be heading strongly north, back towards 300p.
marmar80: When they announced contract loss the share price tanked by 50% and still is almost 40% down.
mallorca 9: (Sharecast News) - Analysts at Berenberg slashed their target price on diversified healthcare and industrial company Scapa on Tuesday, but said the group's "positive start" to the year should restore some investor confidence. Berenberg cut its price target on the group from 520p to 300p but said that Scapa's first-quarter figures, released earlier in the day, showed that things were "not all doom and gloom" for the business, which revealed organic growth in both divisions. The bank said Scapa's first-quarter trading update was "solid", with revenues increasing 34.6% on a continuing FX basis. Berenberg noted that even when excluding Scapa's recent contract wins with ConvaTec and Systagenix, the group still delivered 3% organic growth in its industrial business and 4% in its healthcare division. "In the context of the current share price fall, we think this is a good result," said the German bank. "With positive trading and Scapa clearly confident enough about its case versus CVT (it recently decided to pursue legal action), we feel that the risk is skewed to the upside." However, Berenberg did opt to adjust its numbers to reflect lost ConvaTec revenues of £27m and underlying earnings of £13m, bringing it in line with consensus. While Berenberg lowered its price target on the company, the analysts said they still believe in Scapa's long-term story and confidently reiterated their 'buy' rating on the stock. As of 1310 BST, Scapa shares had picked up 1.45% to 168p.
aztec786: Scapa share price seems to be doin well. P/E ratio of 8 makes this a serious bargain. Thx Mallorca
hopefuldave: Worry!!cant get used to losing money. This is quite a drop but I am now focusing on the quality of scapa, and a return to a higher share price soon I hope.
mallorca 9: Normally I'd be wary of 'catching a falling knife' however Directors buying solid report just issued dividend increased by 20% new plant opened in India 8% sales growth in Asia Completed acquisition Just can't see anything but an eventual recovery in the share price here.
woodhawk: "Do you seriously think scapa will come back from this continuous fall in its share price? If yes, based on what?" 1) Yes 2) Long experience of being a contrarian. That enough for you HopelessDave? One day you'll learn that you have to think ahead in this game and not follow the herd.
hopefuldave: Do you seriously think scapa will come back from this continuous fall in its share price? If yes, based on what?
robow: from The Daily Telegraph Questor: money flows out of Scapa but readers should resist any temptation to join the flood Questor Inheritance Tax Portfolio: after a torrid month for the tapes maker – the loss of its boss and a big contract – things are now looking more rosy It’s been an eventful few weeks for Scapa, the maker of industrial and medical tapes tipped here in March last year at 471.4p. On May 21 it published perfectly satisfactory full-year results but unnerved the market somewhat by announcing that its chief executive, Heejae Chae, who had largely steered the company’s successful restructuring, was stepping down. Two weeks later came a much bigger bombshell: Scapa said it had received notice from a large customer, ConvaTec, that it was terminating a contract in North America worth about $30m (£24m) a year in sales. The shares lost 47pc. Then on Monday this week the company said Mr Chae had agreed to rescind his resignation and would stay on “to execute the current strategy” Keith Ashworth-Lord, who holds Scapa in his SDL UK Buffettology fund, told Questor: “The results in May were nothing other than good, but Chae’s retirement was a bolt from the blue. He is regarded as the architect of the firm in its present form and the market thought there were no succession plans. “Then, when the ConvaTec announcement came, investors put two and two together, came up with five and crucified the share price.” He added: “Last week a group of shareholders, including us, tried to get him to change his mind and convince the market that he hadn’t resigned over ConvaTec. We got the result we wanted this week and the shares have recovered to about 195p.” He said the loss of the contract was “material but not the roof falling in”. “Chae will stay until the problems are solved and that will give Scapa time to sort out the succession,” he added. “This holding has not been my finest but we are sticking with it. We bought more shares heavily after the fall – about 800,000 at various prices as low as 159p. We think it’s been an absolutely classic overreaction by the market. Personally I’m very relaxed about the whole thing.” Questor: hold Ticker: SCPA Share price at close: 199p
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200227 09:24:18